Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Christa Roe, RN, BS, OCN, Jennifer Rock-Klotz, BA, Elyce Turba, RN, MSN, OCN, Christopher Rodriguez Salamanca, PA, Janice Bennett, MS, ARNP-C, Farrah Farquharson, PA, Sem Bastien, MS, ARNP-C, Barbara Williams, RN, BS, OCN, Rebecca Levy, MS, ARNP-C, Yibo Li, BS, Michael Montejo, MD, Ernesto Ayala, MD, Pedro Horna, MD, Lewis F Glass, MD, Rami S. Komrokji, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 1546.

https://doi.org/10.1182/blood.V126.23.1546.1546

Published: 2015

Journal Articles

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Javier Pinilla-Ibarz, Julio C Chavez, MD, Elyce Turba, RN, MSN, OCN, Lisa Nodzon, PhDANP, Jennifer rock-Klotz, BA, Samir Dalia, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Celeste M. Bello, MD

Blood (2015) 126 (23): 2941.

https://doi.org/10.1182/blood.V126.23.2941.2941

Published: 2015

Journal Articles

Histone Deacetylase 11 (HDAC11) Is a Novel Regulator In The Expansion Of MDSCs Via The Transcription Factor C/EBP-β

Jie Chen, M.A., John Powers, B.S., Jennifer Rock-Klotz, B.S., Susan Deng, B.S., Allison Distler, B.S., Fengdong Cheng, MD, Alejandro Villagra, PhD, Eduardo M. Sotomayor, MD, Eva Sahakian, Ph.D, Javier Pinilla-Ibarz, MD, PhD

Blood (2013) 122 (21): 4887.

https://doi.org/10.1182/blood.V122.21.4887.4887

Published: 2013

Journal Articles

A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis

Eva Sahakian, Ph.D, John Powers, B.S., Jie Chen, M.A., Allison Distler, B.S., Jennifer Rock-Klotz, B.S., Susan Deng, B.S., Sheng Wei, MD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, M.D. Ph.D., Pedro Horna, M.D.

Blood (2013) 122 (21): 2267.

https://doi.org/10.1182/blood.V122.21.2267.2267

Published: 2013

Journal Articles

Combination of ACY1215, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor with the Bruton Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, Represents a Novel Therapeutic Strategy in Mantle Cell Lymphoma (MCL)

Eva Sahakian, Ph.D, Jennifer Rock-Klotz, B.S., Bijal D. Shah, MD, John Powers, B.S., Jennifer L. Cultrera, MD, Susan Deng, David M Woods, M.S., Michael Nguyen, Fengdong Cheng, MD, Hongwei Wang, Patricio Perez-Villarroel, B.S., Maritza Lienlaf, B.S., Tesa Knox, M.S., Selina Chen-Kiang, PhD, Alejandro Villagra, PhD, Jianguo Tao, MD, PhD, Javier Pinilla-Ibarz, MD, PhD, Simon S Jones, Eduardo M. Sotomayor, MD

Blood (2012) 120 (21): 1660.

https://doi.org/10.1182/blood.V120.21.1660.1660

Published: 2012

Journal Articles

Novel Role of Histone Deacetylase 11 (HDAC11) in Hematopoiesis

Eva Sahakian, Ph.D, John Powers, B.S., Pedro Horna, M.D., Jennifer Rock-Klotz, B.S., Susan Deng, David M Woods, M.S., Michael Nguyen, Karrune V. Woan, PhD, Fengdong Cheng, MD, Alejandro Villagra, PhD, Dmitry Gabrilovich, MD, PhD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD, PhD

Blood (2012) 120 (21): 4728.

https://doi.org/10.1182/blood.V120.21.4728.4728

Published: 2012

Journal Articles

Histone Deacetylase 11 (HDAC11) Regulates Cytotoxic T-Cell Function and Memory Phenotype

David M Woods, M.S., Karrune V. Woan, PhD, Eva Sahakian, Ph.D, John Powers, B.S., Fengdong Cheng, MD, Hongwei Wang, Jennifer Rock-Klotz, B.S., Jeffrey S. Weber, MD, PhD, Alejandro Villagra, PhD, Javier Pinilla-Ibarz, MD, PhD, Eduardo M. Sotomayor, MD

Blood (2012) 120 (21): 840.

https://doi.org/10.1182/blood.V120.21.840.840

Published: 2012

Journal Articles

Physical Interaction of Histone Deacetylase 6 (HDAC6) with STAT3 Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

Blood (2012) 120 (21): 829.

https://doi.org/10.1182/blood.V120.21.829.829

Published: 2012

Journal Articles

A Novel Role of Histone Deacetylase 11 (HDAC11) in Regulation of Myeloid-Derived Suppressor Cell (MDSC) Expansion

Eva Sahakian, Ph.D, John Powers, B.S., Jennifer Rock-Klotz, B.S., Marsilio Adriani, Ph.D, Karrune V. Woan, Oscar Merino, Ajaypal S. Gill, Susan Deng, Fengdong Cheng, MD, Alejandro Villagra, Noreen Luetteke, Edward Seto, Eduardo M. Sotomayor, Ivan M. Borrello, MD, Javier Pinilla-Ibarz, MD, PhD

Blood (2011) 118 (21): 2439.

https://doi.org/10.1182/blood.V118.21.2439.2439

Published: 2011

Journal Articles

The Opposing Role of Histone Deacetylase 10 (HDAC10) and HDAC11 in Proliferation/Survival of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)

Eva Sahakian, Ph.D, Bijal D. Shah, MD, John Powers, B.S., Susan Deng, Oscar Merino, Ajaypal S. Gill, Jennifer Rock-Klotz, B.S., Karrune V. Woan, Lianet Vazquez, Hongwei Wang, MD, Selina Chen-Kiang, PhD, Jianguo Tao, MD, PhD, Alejandro Villagra, Javier Pinilla-Ibarz, MD, PhD, Eduardo M. Sotomayor

Blood (2011) 118 (21): 1363.

https://doi.org/10.1182/blood.V118.21.1363.1363

Published: 2011

Journal Articles

Epigenetic Modulation of STAT3 by Histone Deacetylase 6 (HDAC6) Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

Fengdong Cheng, Zi Wang, Hongwei Wang, Karrune V. Woan, Eva Sahakian, Ph.D, Jennifer Rock Klotz, Liqing Wang, Rongxiang Han, Oscar Merino, Susan Deng, Lianet Vazquez, Ajaypal S. Gill, Danay Marante, John Powers, B.S., Wayne W. Hancock, Javier Pinilla, Edward Seto, Eduardo M. Sotomayor, Alejandro Villagra

Blood (2011) 118 (21): 519.

https://doi.org/10.1182/blood.V118.21.519.519

Published: 2011

Journal Articles

Tubastatin A, a Selective HDAC6 Inhibitor, Enhances Antigen-Presenting Cell (APC) Function and Restores the Responsiveness of Anergic CD4+ T Cells

Hongwei Wang, Zi Wang, Fengdong Cheng, Karrune V. Woan, Jennifer Rock-Klotz, Eva Sahakian, Ph.D, John Powers, B.S., Pinilla Javier, Joel Bergman, Alejandro Villagra, Alan Kozikowski, Eduardo M. Sotomayor

Blood (2011) 118 (21): 520.

https://doi.org/10.1182/blood.V118.21.520.520

Published: 2011

Journal Articles

HDAC Profiling In Mantle Cell Lymphoma Unveils HDAC11 and HDAC10 as Potential Molecular Targets

Bijal D. Shah, MD, Alejandro Villagra, Oscar Merino, Jennifer Rock-Klotz, Karrune Woan, Edward Seto, Peter Martin, FRCPC, MD, MS, John P. Leonard, MD, Selina Chen-Kiang, PhD, Jianguo Tao, MD, PhD, Eduardo M. Sotomayor, MD

Blood (2010) 116 (21): 2506.

https://doi.org/10.1182/blood.V116.21.2506.2506

Published: 2010

Journal Articles

Identification of a Discrete Subpopulation of T-Cells Over-Expressing HDAC11 with a TH17 Phenotype

Karrune Woan, Fengdong Cheng, Hongwei Wang, Jennifer Rock-Klotz, Zi Wang, Yu Yu, Edward Seto, Noreen Luetteke, Xue-Zhong Yu, Alejandro Villagra, Eduardo M. Sotomayor, MD

Blood (2010) 116 (21): 588.

https://doi.org/10.1182/blood.V116.21.588.588

Published: 2010

Journal Articles

Targeting Histone Deacetylase 6 (HDAC6) as a Novel Approach to Overcome T-Cell Anergy.

Fengdong Cheng, Hongwei Wang, Karrune Woan, Jennifer Rock-Klotz, Zi Wang, Oscar Merino, Ajay Gill, Danay Marante, Lianet Vazquez, Edward Seto, Javier Pinilla-Ibarz, MD, Eduardo M. Sotomayor, MD, Alejandro Villagra

Blood (2010) 116 (21): 1483.

https://doi.org/10.1182/blood.V116.21.1483.1483

Published: 2010

NARROW

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Histone Deacetylase 11 (HDAC11) Is a Novel Regulator In The Expansion Of MDSCs Via The Transcription Factor C/EBP-β

A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis

Combination of ACY1215, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor with the Bruton Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, Represents a Novel Therapeutic Strategy in Mantle Cell Lymphoma (MCL)

Novel Role of Histone Deacetylase 11 (HDAC11) in Hematopoiesis

Histone Deacetylase 11 (HDAC11) Regulates Cytotoxic T-Cell Function and Memory Phenotype

Physical Interaction of Histone Deacetylase 6 (HDAC6) with STAT3 Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

A Novel Role of Histone Deacetylase 11 (HDAC11) in Regulation of Myeloid-Derived Suppressor Cell (MDSC) Expansion

The Opposing Role of Histone Deacetylase 10 (HDAC10) and HDAC11 in Proliferation/Survival of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)

Epigenetic Modulation of STAT3 by Histone Deacetylase 6 (HDAC6) Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

Tubastatin A, a Selective HDAC6 Inhibitor, Enhances Antigen-Presenting Cell (APC) Function and Restores the Responsiveness of Anergic CD4+ T Cells

HDAC Profiling In Mantle Cell Lymphoma Unveils HDAC11 and HDAC10 as Potential Molecular Targets

Identification of a Discrete Subpopulation of T-Cells Over-Expressing HDAC11 with a TH17 Phenotype

Targeting Histone Deacetylase 6 (HDAC6) as a Novel Approach to Overcome T-Cell Anergy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only